Trial Profile
Randomized, Double Blinded, Placebo Controlled Trial to Understand Efficacy of Colesevelam in Diarrhea Predominant IBS Patients With Bile Acid Malabsorption
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Colesevelam (Primary)
- Indications Primary bile acid malabsorption
- Focus Therapeutic Use
- 28 Jun 2019 Status changed from recruiting to completed.
- 08 Jan 2019 Planned End Date changed from 20 Nov 2018 to 20 Oct 2019.
- 08 Jan 2019 Planned primary completion date changed from 20 Nov 2018 to 31 May 2019.